RxDoctor Payments Data

Cliff Lin, MD

Psychiatry · Marietta, GANPI 1689963282

Payments from drug & device makers

$1,972in general payments, 2019–2025

Across 112 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$488
  • Takeda Pharmaceuticals U.S.A., Inc.$307
  • Teva Pharmaceuticals USA, Inc.$303
  • Otsuka America Pharmaceutical, Inc.$140
  • Neurocrine Biosciences, Inc.$120
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$101
  • plus $513 from 13 others

What the payments were for

  • Food & beverage$1,972100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,972 in reported general payments places this provider in the 75th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$55,644
Medicare patients
88
Services billed
548

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine33$160,751
Invega SustennaPaliperidone Palmitate30$97,592
VraylarCariprazine Hcl32$44,935
Lurasidone Hcl36$18,117
BelsomraSuvorexant28$13,244
Quetiapine Fumarate78$5,306
Aripiprazole44$4,219
RisperdalRisperidone12$3,453
Duloxetine Hcl79$3,120
Lisdexamfetamine Dimesylate17$3,045
Olanzapine95$2,683
Prazosin Hcl55$2,204
Bupropion XlBupropion Hcl90$1,726
Trazodone Hcl74$1,684
Desvenlafaxine Succinate ErDesvenlafaxine Succinate22$1,677

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$303$160,75133 claims
Johnson & JohnsonInvega Sustenna, Risperdal$89$101,04542 claims
AbbVieVraylar$488$44,93532 claims
MerckBelsomra$14$13,24428 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →